The National Pharmaceutical Regulatory Agency (NPRA) is pleased to announce that the NPRA GCP, GLP, BE and EC Inspection Dashboard is now officially live on the NPRA website.

The development of this dashboard is part of NPRA’s continuous efforts to strengthen regulatory oversight and enhance transparency, in line with the principles of the World Health Organization (WHO) Global Benchmarking Tool (GBT). The dashboard serves as a centralised platform to improve access to inspection-related information under the scope of Good Clinical Practice (GCP), Good Laboratory Practice (GLP), Bioequivalence (BE) Centre inspections and Ethics Committee (EC) inspections.

Through this platform, external stakeholders will be able to access relevant information on NPRA inspection activities, including available annual reports and key inspection-related updates. The publication of this dashboard reflects NPRA’s commitment to promoting transparency, accountability and stakeholder engagement in the regulation and oversight of clinical research, bioequivalence studies, ethics committees and GLP facilities in Malaysia.

NPRA encourages all relevant stakeholders, including clinical trial sponsors, contract research organisations, bioequivalence centres, ethics committees, GLP facilities, researchers and other interested parties, to visit the dashboard and use it as a reference for NPRA inspection-related information.

The dashboard may be accessed via the following link:

NPRA GCP, GLP, BE and EC Inspection Dashboard